These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34641641)

  • 1. Serum Krebs von den Lungen-6 for Predicting the Severity of COVID-19 Lung Injury: A Systematic Review and Meta-Analysis.
    Pramana Witarto A; Samarta Witarto B; Er Putra AJ; Pramudito SL; Rosyid AN
    Iran Biomed J; 2021 Nov; 25(6):381-9. PubMed ID: 34641641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses.
    Naderi N; Rahimzadeh M
    Virology; 2022 Jan; 566():106-113. PubMed ID: 34896901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic roles of KL-6 in disease severity and lung injury in COVID-19 patients: A longitudinal retrospective analysis.
    Deng K; Fan Q; Yang Y; Deng X; He R; Tan Y; Lan Y; Deng X; Pan Y; Wang Y; Guan Y; Liu H; Chen F; Mo X; Tan X; Luo C; Wen X; Liu Y; Liu J; Zhang L; Tang X; Hu F; Li F
    J Med Virol; 2021 Apr; 93(4):2505-2512. PubMed ID: 33433006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploratory analysis of serum Krebs von den Lungen-6, blood gas analysis & Brixia score in determining COVID-19 severity & mortality.
    Rosyid AN; Witarto AP; Witarto BS; Putra AJE; Pramudito SL; Soebakti E; Sensusiati AD; Nugraha J; Amin M
    Indian J Med Res; 2024 May; 159(5):468-478. PubMed ID: 39382415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration and correlation analysis of changes in Krebs von den Lungen-6 levels in COVID-19 patients with different types in China.
    Xue M; Zheng P; Bian X; Huang Z; Huang H; Zeng Y; Hu H; Liu X; Zhou L; Sun B; Wu JL; Zhong N
    Biosci Trends; 2020 Sep; 14(4):290-296. PubMed ID: 32565512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
    Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
    Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeks.
    Arnold DT; Donald C; Lyon M; Hamilton FW; Morley AJ; Attwood M; Dipper A; Barratt SL
    PLoS One; 2021; 16(4):e0249607. PubMed ID: 33914762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of Krebs von den Lungen-6 and fibronectin with pulmonary fibrosis in coronavirus disease 2019.
    Peng DH; Luo Y; Huang LJ; Liao FL; Liu YY; Tang P; Hu HN; Chen W
    Clin Chim Acta; 2021 Jun; 517():48-53. PubMed ID: 33631198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Krebs von den Lungen-6 levels are associated with mortality and severity in patients with coronavirus disease 2019.
    Yamaya T; Hagiwara E; Baba T; Kitayama T; Murohashi K; Higa K; Sato Y; Otoshi R; Tabata E; Shintani R; Okabayashi H; Ikeda S; Niwa T; Nakazawa A; Oda T; Okuda R; Sekine A; Kitamura H; Komatsu S; Ogura T
    Respir Investig; 2021 Sep; 59(5):596-601. PubMed ID: 33965361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease.
    Qin H; Xu XP; Zou J; Zhao XJ; Wu HW; Zha QF; Chen S; Kang Y; Jiang HD
    Pulmonology; 2019; 25(3):143-148. PubMed ID: 30007895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Could KL-6 levels in COVID-19 help to predict lung disease?
    Frix AN; Schoneveld L; Ladang A; Henket M; Duysinx B; Vaillant F; Misset B; Moutschen M; Louis R; Cavalier E; Guiot J
    Respir Res; 2020 Nov; 21(1):309. PubMed ID: 33234132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019.
    Awano N; Inomata M; Kuse N; Tone M; Takada K; Muto Y; Fujimoto K; Akagi Y; Mawatari M; Ueda A; Izumo T
    Respir Investig; 2020 Nov; 58(6):440-447. PubMed ID: 32863199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Krebs von den Lungen-6 for Predicting the Severity of COVID-19: A Systematic Review, Meta-Analysis, and Trial Sequence Analysis.
    Shrestha AB; Pokharel P; Singh H; Shrestha S; Fioni
    Clin Med Insights Circ Respir Pulm Med; 2023; 17():11795484231152304. PubMed ID: 36710717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Krebs von den Lungen glycoprotein, lung injury, and noninvasive ventilation in Duchenne muscular dystrophy.
    Hamada S; Ishikawa Y; Aoyagi T; Ishikawa Y; Minami R; Bach JR
    Am J Phys Med Rehabil; 2012 Oct; 91(10):831-5. PubMed ID: 22760105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum KL-6 concentrations as a novel biomarker of severe COVID-19.
    d'Alessandro M; Cameli P; Refini RM; Bergantini L; Alonzi V; Lanzarone N; Bennett D; Rana GD; Montagnani F; Scolletta S; Franchi F; Frediani B; Valente S; Mazzei MA; Bonella F; Bargagli E
    J Med Virol; 2020 Oct; 92(10):2216-2220. PubMed ID: 32470148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of serum Krebs von den Lungen-6 levels in patients with coronavirus disease 2019.
    Chen H; Qin R; Huang Z; Luo W; Zheng P; Huang H; Hu H; Wang H; Sun B
    Cytokine; 2021 Dec; 148():155513. PubMed ID: 34507246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Krebs Von den Lungen-6 as a predictive indicator for the risk of secondary pulmonary fibrosis and its reversibility in COVID-19 patients.
    Xue M; Zhang T; Chen H; Zeng Y; Lin R; Zhen Y; Li N; Huang Z; Hu H; Zhou L; Wang H; Zhang XD; Sun B
    Int J Biol Sci; 2021; 17(6):1565-1573. PubMed ID: 33907520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II.
    d'Alessandro M; Bergantini L; Cavallaro D; Gangi S; Cameli P; Conticini E; Siena Covid Unit ; Frediani B; Dotta F; Bargagli E
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Krebs von den Lungen-6 (KL-6) as a diagnostic marker for pulmonary fibrosis: A systematic review and meta-analysis.
    Wang C; Wang Q; Liu T; Zhu J; Zhang B
    Clin Biochem; 2023 Apr; 114():30-38. PubMed ID: 36706799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Krebs von den lungen-6 as a clinical marker for hypersensitivity pneumonitis: A meta-analysis and bioinformatics analysis.
    He J; Zhang J; Ren X
    Front Immunol; 2022; 13():1041098. PubMed ID: 36532009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.